Investigators find window of vulnerability for STIs to infect female reproductive tract

March 16, 2015, The Geisel School of Medicine at Dartmouth

Charles R. Wira, PhD, and colleagues at Dartmouth's Geisel School of Medicine have presented a comprehensive review of the role of sex hormones in the geography of the female reproductive tract and evidence supporting a "window of vulnerability" to HIV and other sexually transmitted infections (STIs). Published in Nature Reviews in Immunology, Wira's team presents a body of work that National Institutes of Health evaluators called, "a sea change" for research in the female reproductive tract (FRT).

"The FRT is tremendously complex and the normal changes that occur to hormones during the are set up to optimize conditions for implantation and pregnancy. To facilitate implantation during the second half of the menstrual cycle, the hormones suppress normally protective activities to allow pregnancy to progress, which would otherwise be prevented," explained Wira. "Our overall goal is to understand the underlying molecular mechanisms through which hormonal changes affect implantation."

The benefits of these findings, said author Marta Rodriguez-Garcia, PhD, are directly applicable to other reproductive challenges including gynecological cancers such as cervical cancer, which is a product of (HPV), infection, infertility, and the epidemic spread of STIs.

"We were drawn to the conclusion that the 'window of vulnerability' created to ensure pregnancy also provides an opportunity for a potential pathogenic bugs like HIV or HPV to enter and infect the FRT," Wira said. He noted that all aspects of the immune system are precisely regulated by the estradiol and progesterone, which are secreted during the menstrual cycle. They affect epithelial cells, fibroblasts, and immune cells in the FRT to modify their functions and, hence, the individual's susceptibility to STIs in ways that are unique to specific sites in the FRT.

In the future, the "window of vulnerability" will lead to concept changes at several levels. At the biological level, determining where and when infections occur could lead to development of new delivery systems for microbicides that are menstrual-cycle dependent. The studies could lead to new concepts for therapeutics that confer protection by enhancing intracellular anti-viral activity. And, at the behavioral level, it could lead to changes in sexual activity, such as the identification of a safer time in the cycle to have sex. In the arena of drug development, there is escalating interest in microbicides, vaccines, and contraceptives, and the Wira studies involving chemical contraceptives will be critical in determining whether certain formulations enhance FRT HIV immune protection without increasing the risk of infection of HIV target cells.

Explore further: Entire female reproductive tract susceptible to HIV infection in macaque model

More information: "The Role of Sex Hormones in Immune Protection of the Female Reproductive Tract" Nature Reviews in Immunology, www.nature.com/nri/journal/vao … nt/full/nri3819.html

Related Stories

Entire female reproductive tract susceptible to HIV infection in macaque model

October 9, 2014
Most women are infected with HIV through vaginal intercourse, and without effective vaccines or microbicides, women who cannot negotiate condom use by their partners remain vulnerable. How exactly the virus establishes infection ...

Study finds protein link to sexually transmitted disease susceptibility

February 28, 2013
Monash Institute of Medical Research scientists have found a protein in the female reproductive tract that protects against sexually transmitted diseases (STIs) such as chlamydia and herpes simplex virus (HSV).

The brain also produces the sex hormone oestrogen

December 24, 2013
The female sex hormone oestrogen can be produced and released from the brain as well as the ovaries, according to a study.

The first animal model for sexual transmission of HIV

August 15, 2013
Infection by human immunodeficiency virus (HIV) causes acquired immunodeficiency syndrome (AIDS), a debilitating disorder in which progressive weakening of the immune system makes affected individuals more susceptible to ...

Semen directly impairs effectiveness of microbicides that target HIV

November 12, 2014
In the fight against HIV, microbicides—chemical compounds that can be applied topically to the female genital tract to protect against sexually transmitted infections—have been touted as an effective alternative to condoms. ...

Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum

April 17, 2014
Population Council scientists and their partners have found that their proprietary microbicide gel is safe, stable, and can prevent the transmission of multiple sexually transmitted infections (STIs) in both the vagina and ...

Recommended for you

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.